• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓内和髓外浆细胞异常增生症的临床和生物学特征

Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias.

作者信息

Janjetovic Snjezana, Lohneis Philipp, Nogai Axel, Balci Derya, Rasche Leo, Jähne Doris, Bokemeyer Carsten, Schilling Georgia, Blau Igor Wolfgang, Schmidt-Hieber Martin

机构信息

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Clinic Hamburg-Eppendorf, 20251 Hamburg, Germany.

Clinic of Hematology and Stem Cell Transplantation, HELIOS Clinic Berlin-Buch, 13125 Berlin, Germany.

出版信息

Biology (Basel). 2021 Jul 6;10(7):629. doi: 10.3390/biology10070629.

DOI:10.3390/biology10070629
PMID:34356484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8301115/
Abstract

Extramedullary plasma cell (PC) disorders may occur as extramedullary disease in multiple myeloma (MM-EMD) or as primary extramedullary plasmocytoma (pEMP)/solitary osseous plasmocytoma (SOP). In this study, we aimed to obtain insights into the molecular mechanisms of extramedullary spread of clonal PC. Clinical and biological characteristics of 87 patients with MM-EMD ( = 49), pEMP/SOP ( = 20) and classical MM ( = 18) were analyzed by using immunohistochemistry (CXCR4, CD31, CD44 and CD81 staining) and cytoplasmic immunoglobulin staining combined with fluorescence hybridization (cIg-FISH). High expression of CD44, a cell-surface glycoprotein involved in cell-cell interactions, was significantly enriched in MM-EMD (90%) . pEMP/SOP (27%) or classical MM (33%) ( < 0.001). In addition, 1q21 amplification by clonal PC occurred at a similar frequency of MM-EMD (33%), pEMP/SOP (57%) and classical MM (44%). Conversely, del(17p13), t(4;14) and t(14;16) were completely absent in pEMP/SOP. Besides this, 1q21 amplification was identified in 64% of not paraskeletal samples from MM-EMD or pEMP compared to 9% of SOP or paraskeletal MM-EMD/pEMP and 44% of classical MM samples, respectively ( = 0.02). Expression of molecules involved in homing and cytogenetic aberrations differ between MM with or without EMD and pEMP/SOP.

摘要

髓外浆细胞(PC)疾病可作为多发性骨髓瘤的髓外疾病(MM-EMD)出现,或作为原发性髓外浆细胞瘤(pEMP)/孤立性骨浆细胞瘤(SOP)出现。在本研究中,我们旨在深入了解克隆性PC髓外扩散的分子机制。通过免疫组织化学(CXCR4、CD31、CD44和CD81染色)和细胞质免疫球蛋白染色结合荧光原位杂交(cIg-FISH)分析了87例MM-EMD(n = 49)、pEMP/SOP(n = 20)和经典MM(n = 18)患者的临床和生物学特征。参与细胞间相互作用的细胞表面糖蛋白CD44的高表达在MM-EMD(90%)中显著富集,而在pEMP/SOP(27%)或经典MM(33%)中则不然(P < 0.001)。此外,克隆性PC的1q21扩增在MM-EMD(33%)、pEMP/SOP(57%)和经典MM(44%)中出现的频率相似。相反,pEMP/SOP中完全不存在del(17p13)、t(4;14)和t(14;16)。除此之外,与SOP或骨旁MM-EMD/pEMP的9%以及经典MM样本的44%相比,MM-EMD或pEMP的非骨旁样本中分别有64%检测到1q21扩增(P = 0.02)。伴有或不伴有EMD的MM与pEMP/SOP之间参与归巢的分子表达和细胞遗传学异常存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/ea836ac24a20/biology-10-00629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/5eb9b85d49a7/biology-10-00629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/4d0251bb47da/biology-10-00629-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/18c0faf44c28/biology-10-00629-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/ea836ac24a20/biology-10-00629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/5eb9b85d49a7/biology-10-00629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/4d0251bb47da/biology-10-00629-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/18c0faf44c28/biology-10-00629-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb0b/8301115/ea836ac24a20/biology-10-00629-g004.jpg

相似文献

1
Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias.髓内和髓外浆细胞异常增生症的临床和生物学特征
Biology (Basel). 2021 Jul 6;10(7):629. doi: 10.3390/biology10070629.
2
Cytogenetics of extramedullary manifestations in multiple myeloma.多发性骨髓瘤髓外表现的细胞遗传学研究。
Br J Haematol. 2013 Apr;161(1):87-94. doi: 10.1111/bjh.12223. Epub 2013 Feb 1.
3
Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance.多发性骨髓瘤的髓外表现具有细胞遗传学异常不良和对新型药物耐药的高发生率。
Biomed Res Int. 2015;2015:787809. doi: 10.1155/2015/787809. Epub 2015 Apr 23.
4
MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma.MYC 易位是多发性骨髓瘤髓外疾病发展和复发的一个有价值的标志物。
Eur J Haematol. 2024 Dec;113(6):824-832. doi: 10.1111/ejh.14296. Epub 2024 Aug 27.
5
Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease.315例多发性骨髓瘤患者的细胞遗传学和生存分析;5例有眼眶病变,8例有髓外疾病。
Orbit. 2023 Dec;42(6):603-611. doi: 10.1080/01676830.2023.2166082. Epub 2023 Jan 25.
6
Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.浆细胞肿瘤的风险分层:浆细胞特异性细胞质免疫球蛋白荧光原位杂交(cIg FISH)与常规 FISH 的比较。
Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):366-74. doi: 10.1016/j.clml.2012.05.003. Epub 2012 Jun 1.
7
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.接受干细胞移植患者的髓外多发性骨髓瘤的发病率及临床特征
Br J Haematol. 2015 Jun;169(6):851-8. doi: 10.1111/bjh.13383. Epub 2015 Apr 1.
8
Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.多发性骨髓瘤髓外疾病的特征:p53缺失频率高及生存率低:一项对834例病例的回顾性单中心研究
Clin Lymphoma Myeloma Leuk. 2015 May;15(5):286-91. doi: 10.1016/j.clml.2014.12.013. Epub 2015 Jan 3.
9
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns.依洛珠单抗治疗骨髓外多发性骨髓瘤:临床疗效和 SLAMF7 表达模式的回顾性分析。
Ann Hematol. 2021 Jun;100(6):1537-1546. doi: 10.1007/s00277-021-04447-6. Epub 2021 Feb 11.
10
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.自体干细胞移植联合治疗对伴有髓外疾病和高危细胞遗传学的新诊断多发性骨髓瘤的疗效改善:来自欧洲血液和骨髓移植学会慢性恶性肿瘤工作组的研究。
Biol Blood Marrow Transplant. 2019 Nov;25(11):2134-2142. doi: 10.1016/j.bbmt.2019.07.004. Epub 2019 Jul 6.

引用本文的文献

1
α-Amino bisphosphonate triazoles serve as GGDPS inhibitors.α-氨基双膦酸三唑类化合物可作为 GGDPS 抑制剂。
Bioorg Med Chem Lett. 2024 Apr 1;102:129659. doi: 10.1016/j.bmcl.2024.129659. Epub 2024 Feb 17.
2
Skeletal muscle extramedullary plasmacytoma transformed into plasmablastic plasmacytoma: a case report.骨外髓外浆细胞瘤转化为浆母细胞性浆细胞瘤:一例报告。
J Cancer Res Clin Oncol. 2024 Feb 1;150(2):65. doi: 10.1007/s00432-023-05604-2.
3
Interaction between age and gender on survival outcomes in extramedullary multiple myeloma over the past two decades.

本文引用的文献

1
Long-term Outcomes After Definitive Radiation Therapy for Solitary Plasmacytoma.孤立性浆细胞瘤根治性放疗的长期结果。
Am J Clin Oncol. 2020 Oct;43(10):709-713. doi: 10.1097/COC.0000000000000734.
2
Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis.浆细胞骨髓瘤中 CD81 和 CD117 的表达及其与预后的关系。
Cancer Med. 2018 Dec;7(12):5920-5927. doi: 10.1002/cam4.1840. Epub 2018 Oct 24.
3
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.
过去二十年中,年龄与性别在髓外多发性骨髓瘤生存结局上的相互作用。
World J Clin Oncol. 2023 Apr 24;14(4):179-189. doi: 10.5306/wjco.v14.i4.179.
孤立性浆细胞瘤的诊断、治疗和反应评估:欧洲专家小组的最新建议。
J Hematol Oncol. 2018 Jan 16;11(1):10. doi: 10.1186/s13045-017-0549-1.
4
Cytogenetics in multiple myeloma patients progressing into extramedullary disease.进展为髓外疾病的多发性骨髓瘤患者的细胞遗传学
Eur J Haematol. 2016 Jul;97(1):93-100. doi: 10.1111/ejh.12688. Epub 2015 Oct 19.
5
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.多发性骨髓瘤修订国际分期系统:国际骨髓瘤工作组报告
J Clin Oncol. 2015 Sep 10;33(26):2863-9. doi: 10.1200/JCO.2015.61.2267. Epub 2015 Aug 3.
6
CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.CXCR4通过上皮-间质转化样转录激活调控髓外骨髓瘤。
Cell Rep. 2015 Jul 28;12(4):622-35. doi: 10.1016/j.celrep.2015.06.059. Epub 2015 Jul 16.
7
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.接受干细胞移植患者的髓外多发性骨髓瘤的发病率及临床特征
Br J Haematol. 2015 Jun;169(6):851-8. doi: 10.1111/bjh.13383. Epub 2015 Apr 1.
8
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
9
CD31 expression in plasmacytic/plasmablastic lesions.浆细胞性/浆母细胞性病变中的CD31表达。
Ann Diagn Pathol. 2013 Dec;17(6):498-501. doi: 10.1016/j.anndiagpath.2013.08.003. Epub 2013 Sep 24.
10
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.软组织髓外多发性骨髓瘤的预后明显比骨相关髓外复发差。
Haematologica. 2014 Feb;99(2):360-4. doi: 10.3324/haematol.2013.094409. Epub 2013 Sep 13.